Order byBest matchMost fresh
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.
COVID vaccines are only approved for elderly and a few others as RFK continues to reshape how Americans fight disease
The change was announced by the Food and Drug Administration, which falls under Health and Human Services. While Secretary Robert F. Kennedy Jr. didn’t have a direct role in the new change, it exemplifies how the vaccine skeptic is reshaping how Americans fight diseases.
COVID vaccine changes & political music debate
The FDA announces changes for who's eligible for the COVID-19 vaccine. Plus, should musicians shut up & sing or tell critics to kick rocks? A PR guru weighs in
RFK Jr. pledged not to upend US vaccine system, but big changes are underway
Health agencies working under Robert F. Kennedy Jr. are making changes to the nation's decades-old system for approving and recommending vaccines.
STAT9d
Beyond politics, even U.S. vaccine experts may envision fewer Covid shots in the future
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
Live Science on MSN1d
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
RFK Jr’s FDA limits use of Covid vaccine
Kennedy’s FDA approved the use of the Novavax Covid-19 vaccine, but with strict conditions. It will only be made available to older people and those over the age of 12 with at least one medical condition that leaves them at high risk from Covid, The New York Times reported.
House GOP requests records from Pfizer CEO and former executive in probe of Covid vaccine delay allegation
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the development of the company’s Covid-19 vaccine was purposefully delayed until after the 2020 presidential election.
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift
Vaccine maker’s £1bn UK investment to create ‘hundreds of high-skilled jobs’
Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the UK over the next 10 years. The planned investment would be one of the biggest in the history of UK life sciences, the Department for Science, Innovation and Technology said.
Feedback